Skip to main content
Average ER Wait Time
Checking ER Wait Time
The feed could not be reached
Retry?
Menorah Medical Center
--
mins

Menorah Medical Center Introduces Scalp-Cooling Technology to Lessen Chemotherapy-Induced Hair Loss

Menorah Medical Center June 15, 2016

Hair loss is one of the most obvious and unwanted side effects of chemotherapy treatment for cancer patients, but help is here for sufferers in Kansas City. Sarah Cannon Cancer Center at Menorah Medical Center—part of HCA Midwest Health, Kansas City’s leading healthcare provider—recently installed the DigniCap System. Recognized as the most scientifically advanced treatment for chemotherapy-induced hair loss available, the FDA-approved scalp-cooling technology is an effective, comfortable and safe option for prevention of hair loss.

Menorah Medical Center is the first Kansas City-area hospital to install DigniCap.

The DigniCap System is the only one that provides scalp cooling at temperatures above freezing; its built-in temperature sensors and precision cooling mechanism facilitate gradual and tolerable temperature fluctuations on the scalp. The system offers continuous monitoring for comfort and consistent treatment application, as well as caps that do not cover the ears so that the patients can still hear during treatment. It also features an intuitive touch-screen control panel.  The DigniCap is designed to work with a woman’s chemotherapy regimen from the initial infusion.

Dr. Stephanie Graff, a board certified physician who specializes in hematology-oncology, commends the technology. “DigniCap has been studied in women on chemotherapy for breast cancer and proven safe while significantly reducing hair loss. Though some might minimize it, hair plays a role in our overall sense of wellness, confidence and quality of life. And those are important components to achieving best cancer care. Investing in this technology was an easy decision.”

“One of the hallmarks of care at Menorah Medical Center is providing solutions for issues that impact patients,” says Charles Laird, Menorah Medical Center Chief Executive Officer. “Offering this particular scalp-cooling system to help mitigate hair loss in chemotherapy patients is part of our comprehensive, compassionate approach to cancer care.”

Menorah Medical Center is part of the Sarah Cannon HCA Midwest Health cancer network, providing local access to innovative clinical research trials, tumor profiling and genetic counseling; allowing patients to receive top, state-of-the-art cancer care close to home. Other Sarah Cannon HCA Midwest Health accredited cancer programs include Sarah Cannon at Belton Regional Medical Center, Accredited Associate Cancer Program; Sarah Cannon at Centerpoint Medical Center, Accredited Community Cancer Program; and Sarah Cannon at Research Medical Center, Accredited Comprehensive Cancer Program.

For more information about cancer care at Sarah Cannon at Menorah Medical Center, visit menorahmedicalcenter.com.

News Related Content